Drug extends survival in lung cancer patients
Combination extends survival vs. standard first-line therapy for advanced lung cancer
A two-drug combination extended OS compared with standard first-line osimertinib for certain patients with advanced lung cancer, according to the agents’ manufacturer.The OS benefit with amivantamab-vmjw (Rybrevant,
Researchers from POSTECH and Kyungpook National University have developed a novel inhalable therapeutic delivery system for ...
Michigan officials are urging residents to test their homes for a dangerous, radioactive gas that is found naturally in the ...
News Medical on MSN10h
Lung cancer deaths decrease globally but risk factors still persistEven though lung and related cancer deaths decreased in the world's 10 most populous countries from 1990 to 2019, these positive statistics do not address trends in mortality linked to tobacco use, ...
Lung and related cancer deaths decreased in the world’s 10 most populous countries over the past 40 years, but there is still ...
Researchers at the Francis Crick Institute, the UCL Cancer Institute and UCLH have shown that a test called ORACLE can ...
Significant advancements in lung cancer treatment were seen throughout 2024, from new drug approvals to promising clinical ...
Lung cancer remains one of the deadliest cancers globally. Non-small cell lung cancer (NSCLC), which accounts for 85% of all lung cancer cases, is particularly challenging to treat due to difficulties ...
Identifying lung cancer at its earliest stage before symptoms develop allows for earlier treatment and the potential for cure ...
Other warning signs of lung cancer include a persistent cough or hoarse voice, changes in a long-standing cough, unexplained ...
Jan. 6, 2025 — Researchers have developed a way of detecting circulating tumor cells in the bloodstream of pancreatic cancer and lung cancer ... Scientists Develop Scans That Light-Up Aggressive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback